Agenus Inc. (AGEN) - Earnings & Price History

AGEN: Agenus Inc. - 3.58, $370.43M, -0.08 (-2.19%)

Sector: Healthcare - Industry: Biotechnology

Agenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the bodys immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates using a high-throughput approach incorporating human antibody libraries expressed in mammalian B-lymphocytes. It is also developing Prophage, a heat shock protein-based autologous vaccine, which has completed Phase II clinical trials for the treatment of glioblastoma; and QS-21 Stimulon, a saponin-based vaccine adjuvant that has completed Phase III clinical trials for the treatment of malaria and shingles. The companys preclinical development products include AutoSynVax, a neo-antigen based vaccine targeting the neo-epitope landscape in cancer patients; PhosphoSynVax, a vaccine candidate desi

Past AGEN reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-09BMO-0.34.063.973.93.94.17-1.76%4.10%2.27%767.24K
2017-03-01BMO-0.34.244.244.344.24.362.36%-2.30%1.32M
2016-10-27BMO-0.34.335.2354.315.19-4.40%▲-13.40%-17.21%4.02M
2016-07-28BMO-0.345.384.934.934.925.429.13%9.13%1.70M
2016-04-28BMO-0.233.844.24.013.814.19-4.52%-4.24%-8.57%1.68M
2016-03-03BMO-0.173.43.213.212.983.55.92%5.92%1.89M
2015-10-27-0.114.724.754.764.534.830.21%▲-0.84%-0.63%1.82M
2015-07-23-0.158.568.959.098.519.231.56%-5.83%-4.36%1.64M
2015-04-23-0.017.126.376.56.457.452.04%9.54%11.77%4.84M
2015-03-06BMO-0.015.115.285.285.095.28-3.22%-3.22%551.33K
2015-03-05BMO-0.015.285.095.095.075.383.73%3.73%817.78K
2015-03-04BMO-0.015.094.854.844.85.13-0.21%5.17%4.95%735.01K
2015-03-03BMO-0.014.854.884.854.76354.93-0.61%-0.61%667.05K
2015-02-26BMO-0.165.045.55.224.95.22-5.09%-3.45%-8.36%1.87M
2014-10-31BMOAgenus Inc-0.16-0.132.983.093.182.893.182.91%▲-6.29%-3.56%610.70K
2014-07-24BMOAgenus Inc-0.11-0.123.393.053.223.173.45.57%5.28%11.15%1.93M
2014-05-08BMOAgenus Inc-0.160.012.492.712.752.482.751.48%-9.45%-8.12%522.20K
2014-03-05BMOAgenus Inc-0.23-0.164.974.764.754.755.18-0.21%4.63%4.41%1.37M
2013-10-24BMOAgenus Inc-0.28-0.242.532.542.552.512.620.39%▲-0.78%-0.39%275.70K
2013-07-25BMOAgenus Inc-0.21-0.43.73.813.793.693.79-0.52%-2.37%-2.89%264.60K
2013-04-24BMO-0.234.584.64.64.424.7-0.43%-0.43%468.64K
2013-02-28BMO-0.244.284.114.174.134.34991.46%2.64%4.14%57.79K
2012-10-25BMO-0.294.654.434.5154.464.651.92%▲2.99%4.97%146.54K
2012-08-02BMOQ2 2012 Agenus Inc. -0.27-0.314.684.824.84.664.93-0.41%-2.50%-2.90%112.20K
2012-04-26Agenus Inc-0.290.296.16.436.456.036.450.31%-5.43%-5.13%210.10K
2012-04-25BMOQ1 2012 Agenus Inc. -0.280.296.286.326.476.166.52.37%-2.94%-0.63%246.90K
2012-03-05BMOQ4 2011 Agenus Inc E-0.28-0.293.213.233.4933.498.05%-8.02%-0.62%236.80K
2011-10-27BMOQ3 2011 Agenus Inc E-0.282.782.72.82.662.823.70%▲-0.71%2.96%152.80K
2011-07-28BMOQ2 2011 Agenus Inc E-0.30.780.770.770.760.81.30%1.30%18.10K
2011-04-28BMOQ1 2011 Antigenics I-0.24-0.30.940.960.950.920.97-1.04%-1.05%-2.08%39.00K
2011-02-17BMOQ4 2010 Antigenics I-0.3-0.180.940.930.930.90.941.08%1.08%30.20K
2010-10-28BMOQ3 2010 Antigenics I-0.360.910.9610.914.17%▲-9.00%-5.21%81.60K
2010-07-29BMOQ2 2010 Antigenics I-0.30.870.920.950.830.953.26%-8.42%-5.43%109.30K
2010-04-29BMOQ1 2010 Antigenics I-0.36-0.61.231.141.131.071.33-0.88%8.85%7.89%1.23M
2010-02-18BMOQ4 2009 Antigenics I-0.540.120.750.810.790.740.81-2.47%-5.06%-7.41%148.50K
2009-10-29BMOQ3 2009 Antigenics I-0.66-0.781.011.071.11.011.132.80%▲-8.18%-5.61%345.60K
2009-07-30BMOQ2 2009 Antigenics I-1.022.382.62.372.262.64-8.85%0.42%-8.46%839.90K
2009-05-07BMOQ1 2009 Antigenics I-0.72-0.840.710.70.720.70.742.86%-1.39%1.43%65.40K
2009-02-19BMOQ4 2008 Antigenics I-0.960.480.450.450.520.450.5215.56%-13.46%7.20K
2008-11-05BMOQ3 2008 Antigenics I-1.08-1.020.790.790.80.780.81.27%▲-1.25%8.20K
2008-07-31BMOQ2 2008 Antigenics I-1.08-1.141.971.941.91.91.99-2.06%3.68%1.55%53.60K
2008-05-01BMOQ1 2008 Antigenics I-0.84-1.22.172.262.22.172.26-2.65%-1.36%-3.98%48.20K
2008-02-21BMOQ4 2007 Antigenics I-1.38-0.962.132.22.142.12.29-2.73%-0.47%-3.18%34.30K
2007-11-01BMOQ3 2007 Antigenics I-1.38-1.52.482.562.52.442.57-2.34%▲-0.80%-3.12%32.20K
2007-08-02BMOQ2 2007 Antigenics I-1.322.942.913.052.93.14.81%-3.61%1.03%123.00K
2007-05-08BMOQ1 2007 Antigenics I-1.142.873.0332.813.04-0.99%-4.33%-5.28%70.30K
2007-02-21BMOQ4 2006 Antigenics I-1.26-1.561.991.9921.972.050.50%-0.50%11.00K
2006-10-31BMOQ3 2006 Antigenics I-1.34-1.442.192.0121.922.19-0.50%▲9.50%8.96%29.30K
2006-08-01BMOQ2 2006 Antigenics I-1.42-1.861.811.771.81.731.811.69%0.56%2.26%16.10K
2006-05-03BMOQ1 2006 Antigenics I-2.1-2.162.081.9921.972.10.50%4.00%4.52%89.80K
2006-02-23BMOQ4 2005 Antigenics I-2.58-2.346.346.836.86.166.9-0.44%-6.76%-7.17%119.60K
2005-10-27BMOQ3 2005 Antigenics I-2.58-2.285.15.435.535.15.531.84%▲-7.78%-6.08%112.90K
2005-07-28BMOQ2 2005 Antigenics I-2.44-2.825.866.056.015.76.17-0.66%-2.50%-3.14%90.40K
2005-05-05BMOQ1 2005 Antigenics I-2.35-2.47.27.167.1577.2-0.14%0.70%0.56%83.30K
2005-02-24BMOQ4 2004 Antigenics I7.447.557.557.257.77-1.46%-1.46%53.90K
2004-10-19BMOQ3 2004 Antigenics I4.885.865.874.85.870.17%▲-16.87%-16.72%438.00K
2004-07-22BMOQ2 2004 Antigenics I7.677.667.77.417.920.52%-0.39%0.13%80.20K
2004-04-20BMOQ1 2004 Antigenics I10.6211.0610.8810.0711.14-1.63%-2.39%-3.98%174.80K
2004-02-19BMOQ4 and FY 2003 Antig10.110.310.49.9310.440.97%-2.88%-1.94%108.70K
2003-10-23BMOQ3 2003 Antigenics I11.9112.2612.111.3512.15-1.31%▲-1.57%-2.85%76.90K
2003-07-23BMOQ2 2003 Antigenics I12.461212.0111.812.580.08%3.75%3.83%44.60K
2003-04-16BMOQ1 2003 Antigenics I8.2388.087.848.751.00%1.86%2.87%47.00K
2003-02-19BMOQ4 2002 Antigenics I8.298.738.738.128.74-5.04%-5.04%37.30K
2002-10-23BMOQ3 2002 Antigenics E8.88.718.828.288.821.26%▲-0.23%1.03%40.70K
2002-07-25BMOQ2 2002 Antigenics E8.478.58.57.948.5-0.35%-0.35%27.10K
2002-04-23Q1 2002 Antigenics E12.5312.1312.2512.1512.610.99%2.29%3.30%35.10K
2002-02-20BMOQ4 2001 Antigenics E12.0311.912.111.9512.71.68%-0.58%1.09%42.50K
2001-10-23BMOQ3 2001 Antigenics E15.0115.8715.715.0116-1.07%▲-4.39%-5.42%8.40K
2001-07-24BMOQ2 2001 Antigenics E16.0116.7416.9515.9916.991.25%-5.55%-4.36%40.20K
2001-04-24BMOQ1 2001 Antigenics E17.2515.5515.4515.317.28-0.64%11.65%10.93%59.90K
2001-02-21BMOQ4 2000 Antigenics E1515.4815.1314.8815.38-2.26%-0.86%-3.10%6.20K
2000-10-26Q3 2000 Antigenics E14.2515.0614.941415.5-0.80%▲-4.62%-5.38%8.60K
2000-07-25Q2 2000 Antigenics E1817.691817181.75%1.75%5.20K
2000-04-24Antigenics Earnings 15.251515.3414.8115.52.27%-0.59%1.67%8.40K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades